当前位置:首页 - 行情中心 - 森萱医药(920946) - 财务分析 - 现金流量表

森萱医药

(920946)

  

流通市值:43.66亿  总市值:43.67亿
流通股本:4.27亿   总股本:4.27亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金142,188,427.6522,434,006.33380,143,964.06258,716,727.94
  收到的税费返还26,943.37144,161.95140,946.1836,555.03
  收到其他与经营活动有关的现金1,213,219.1813,075,320.8913,197,695.466,754,615.73
  经营活动现金流入小计143,428,590.15535,653,489.17393,482,605.7265,507,898.7
  购买商品、接受劳务支付的现金38,149,964.73151,798,280.77112,416,302.7572,934,950.59
  支付给职工以及为职工支付的现金37,193,726.14110,745,302.7285,106,146.7560,450,988.08
  支付的各项税费9,946,215.7955,053,150.8143,733,657.9228,325,038.4
  支付其他与经营活动有关的现金4,998,643.2821,298,401.6116,152,357.0211,597,711.12
  经营活动现金流出小计90,288,549.94338,895,135.91257,408,464.44173,308,688.19
  经营活动产生的现金流量净额53,140,040.21196,758,353.26136,074,141.2692,199,210.51
二、投资活动产生的现金流量:
  收回投资收到的现金88,000,000303,000,000207,000,000150,000,000
  取得投资收益收到的现金700,197.572,363,840.691,435,394.92795,663.87
  处置固定资产、无形资产和其他长期资产收回的现金净额-1,800--
  投资活动现金流入小计88,700,197.57305,365,640.69208,435,394.92150,795,663.87
  购建固定资产、无形资产和其他长期资产支付的现金5,196,722.69,590,535.476,522,124.324,216,456.81
  投资支付的现金104,000,000376,000,000306,000,000228,000,000
  支付其他与投资活动有关的现金34,000,00091,000,00071,000,00071,000,000
  投资活动现金流出小计143,196,722.6476,590,535.47383,522,124.32303,216,456.81
  投资活动产生的现金流量净额-54,496,525.03-171,224,894.78-175,086,729.4-152,420,792.94
三、筹资活动产生的现金流量:
  取得借款收到的现金3,000,000-200,000-
  收到其他与筹资活动有关的现金-200,000--
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计3,000,000200,000200,000-
  偿还债务支付的现金200,000---
  分配股利、利润或偿付利息支付的现金12,75062,968,567.662,968,567.662,968,567.6
  其中:子公司支付给少数股东的股利、利润-3,200,0003,200,0003,200,000
  支付其他与筹资活动有关的现金133,0181,267,653.691,194,635.691,134,635.69
  筹资活动现金流出小计345,76864,236,221.2964,163,203.2964,103,203.29
  筹资活动产生的现金流量净额2,654,232-64,036,221.29-63,963,203.29-64,103,203.29
四、汇率变动对现金及现金等价物的影响-1,356,308.31-1,937,713.43-1,223,900.33-368,779.14
五、现金及现金等价物净增加额-58,561.13-40,440,476.24-104,199,691.76-124,693,564.86
  加:期初现金及现金等价物余额542,877,681.42583,318,157.66583,318,157.66583,318,157.66
  期末现金及现金等价物余额542,819,120.29542,877,681.42479,118,465.9458,624,592.8
补充资料:
  净利润-137,770,973.41-70,038,266.11
  资产减值准备-8,929,731.82-4,368,596.75
  固定资产和投资性房地产折旧-46,260,183.39-22,360,315.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-46,260,183.39-22,360,315.9
  无形资产摊销-1,162,341.74-582,160.97
  处置固定资产、无形资产和其他长期资产的损失--2,615.92--4,478.7
  固定资产报废损失-574,522.03--
  公允价值变动损失--1,754,904.05--854,982.69
  财务费用--1,773,658.54--1,142,872.2
  投资损失--959,285.82--420,272.41
  递延所得税-1,952,934.65-136,840.82
  其中:递延所得税资产减少--604,181.12-28,968.45
    递延所得税负债增加-2,557,115.77-107,872.37
  存货的减少-3,139,917.31--7,593,142.06
  经营性应收项目的减少--9,497,360.2-8,223,198.9
  经营性应付项目的增加-8,195,351.81--6,733,774.19
  其他-2,182,163.11-3,516,475.4
  不涉及现金收支的投资和筹资活动金额其他项目-1,093,854.7-123,309.6
  现金的期末余额-542,877,681.42-458,624,592.8
  减:现金的期初余额-583,318,157.66-583,318,157.66
  现金及现金等价物的净增加额--40,440,476.24--124,693,564.86
公告日期2026-04-292026-04-222025-10-292025-08-29
审计意见(境内)标准无保留意见
TOP↑